Clinical Trials

300 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT06170671 2026-03-23

REACH

250 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04635384 2026-03-18

ACROBAT

LymphoidMyeloidOther hematologic neoplasm

307 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07474051 2026-03-16

PERSIST

Enrolling by invitation

178 enrolled

GenitourinaryLymphoidOther hematologic neoplasm

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT02808780 2026-03-13

OPAL

537 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Colitis, Ulcerative, Lymphoma, Neoplasms

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

150 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05557695 2026-03-10

EPIC

350 enrolled

Leukemia, B-Cell

NCT05999877 2026-03-10

PICAROS

192 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05640102 2026-03-04

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

111 enrolled

Waldenstrom Macroglobulinemia

NCT07154823 2026-03-03

Aquarius

550 enrolled

Lymphoma, Follicular, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05437250 2026-03-02

NAOS

350 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07282548 2026-03-02

Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies

Not yet recruiting

63 enrolled

Lymphoma, Follicular

NCT06785818 2026-02-23

Long-term Follow up Local Registry Study of Kymriah in South Korea

500 enrolled

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT07288515 2026-02-23

ALICIA(BY)

50 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06830759 2026-02-17

EpcoReal

700 enrolled

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT06578351 2026-02-04

TRAM

60 enrolled

Dermatitis, Atopic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05954910 2026-02-02

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

1,000 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT06043011 2026-01-28

RUBIN

2,950 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06205498 2026-01-22

ARISE

151 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06357754 2026-01-22

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

LymphoidOther hematologic neoplasmPlasma cell

50 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, B-Cell

NCT05140369 2026-01-21

CLL registry

6,000 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05366881 2026-01-20

CAMPERR

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

7,000 enrolled

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05228158 2026-01-02

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

145 enrolled

Lymphoma, Follicular

NCT04307134 2025-12-31

Besponsa Post Marketing Surveillance Study

108 enrolled 39 charts

Burkitt Lymphoma, Hematologic Neoplasms

NCT04837222 2025-12-24

A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

1,000 enrolled

Lymphoma

NCT06985576 2025-12-18

Long-term Study to Evaluate Safety and Persistence of GF-CART01

Not yet recruiting

18 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Dendritic Cell Sarcoma, Interdigitating

NCT03342144 2025-12-08

VeRVe

500 enrolled

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04746950 2025-12-08

ALICIA

90 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05923112 2025-12-05

BESPONSA Injection 1 mg Special Investigation

421 enrolled 18 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04178317 2025-12-04

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

14 enrolled

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05645172 2025-12-01

RETAIN

137 enrolled

Leukemia, B-Cell

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

200 enrolled

Lymphoma, Follicular, Psoriasis

NCT06362044 2025-11-25

A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan

89 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03816683 2025-11-14

SUMMIT

227 enrolled

Lymphoma, Mantle-Cell

NCT03452774 2025-10-28

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidMyeloidNETOther hematologic neoplasmThoracic

50,000 enrolled

Turcot syndrome, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Primary Myelofibrosis

NCT07189806 2025-09-24

MAPLE-UK

250 enrolled

LymphoidOtherThoracic

Asthma, Bronchial Spasm, Cough, Disease, Dyspnea, Inflammation, Lymphoma, Follicular

NCT05326308 2025-09-23

ARIADNE

705 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT06358001 2025-09-22

EchoTip AcuCore Post-Market Clinical Study

EndocrineGastrointestinalLymphoidNET

183 enrolled

Autoimmune Pancreatitis, Adenocarcinoma, Carcinoma, Hepatocellular, Lymphoma, Neoplasm Metastasis, Cholangiocarcinoma, Neuroendocrine Tumors, Pancreatitis, Chronic

NCT07132567 2025-09-22

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

15 enrolled

Mycosis Fungoides, Sezary Syndrome

NCT05100056 2025-09-09

BV-MAZOVIA

70 enrolled

Hodgkin Disease

NCT06274788 2025-09-05

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

40 enrolled

Malnutrition, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04872621 2025-09-02

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

104 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07145411 2025-08-28

HOPE

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

10 enrolled

Anemia, Aplastic, Anemia, Sickle Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06476665 2025-08-19

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

7 enrolled